Literature DB >> 28556195

Use of nystatin and chlorhexidine in oral medicine: Properties, indications and pitfalls with focus on geriatric patients.

Elusa Scheibler1, Maria Claudia Rosa Garcia2, Renata Medina da Silva2, Maria Antonia Figueiredo1, Fernanda Gonçalves Salum1, Karen Cherubini1.   

Abstract

OBJECTIVES: The aim of this work was to review the scientific literature on the properties, indications and pitfalls related to nystatin and chlorhexidine in oral medicine and also to compare these to other topical antifungal agents, considering the elderly population.
BACKGROUND: Nystatin is a polyene antifungal widely used as a topical formulation to treat candidiasis, whereas chlorhexidine is a wide-spectrum antimicrobial, especially used against bacteria, but also effective in treating some fungal infections including those caused by Candida spp. These compounds have been prescribed for immunocompromised patients, hospitalized or not, some of them undergoing head and neck radiation therapy and/or chemotherapy, including elderly patients.
MATERIALS AND METHODS: Dental and medical literature concerning the use of nystatin and chlorhexidine in oral medicine were selected and reviewed.
RESULTS: Nystatin and chlorhexidine are gold-standard antimicrobial mouthrinses respectively for Candida spp. and bacteria. Although recognized as effective in cotrolling oral infections, both nystatin and chlorhexidine are just complementary to systemic therapy in cases of systemic infections already established. The prescriber should also take into account that some commercial nystatin and chlorhexidine formulations contain compounds such as sugar and ethanol, which can be associated with side effects. Meanwhile, alternative formulations in which these compounds are absent are available and should be considered.
CONCLUSIONS: Further studies investigating new drugs and interactions of drug combinations are necessary to improve the therapeutic management of oral infections.
© 2017 John Wiley & Sons A/S and The Gerodontology Association. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  antifungal agents; candidiasis; chlorhexidine; drug interactions; nystatin

Mesh:

Substances:

Year:  2017        PMID: 28556195     DOI: 10.1111/ger.12278

Source DB:  PubMed          Journal:  Gerodontology        ISSN: 0734-0664            Impact factor:   2.980


  6 in total

1.  Increasing Susceptibility of Drug-Resistant Candida albicans to Fluconazole and Terbinafine by 2(5H)-Furanone Derivative.

Authors:  Irshad S Sharafutdinov; Georgii D Ozhegov; Alina E Sabirova; Valentina V Novikova; Svetlana A Lisovskaya; Alsu M Khabibrakhmanova; Almira R Kurbangalieva; Mikhail I Bogachev; Airat R Kayumov
Journal:  Molecules       Date:  2020-02-02       Impact factor: 4.411

2.  Ellagic Acid-Cyclodextrin Complexes for the Treatment of Oral Candidiasis.

Authors:  Aline da Graça Sampaio; Aline Vidal Lacerda Gontijo; Gabriela de Morais Gouvêa Lima; Maria Alcionéia Carvalho de Oliveira; Laura Soares Souto Lepesqueur; Cristiane Yumi Koga-Ito
Journal:  Molecules       Date:  2021-01-19       Impact factor: 4.411

3.  Nanoparticle carrier co-delivery of complementary antibiofilm drugs abrogates dual species cariogenic biofilm formation in vitro.

Authors:  Guilherme Roncari Rocha; Kenneth R Sims; Baixue Xiao; Marlise I Klein; Danielle S W Benoit
Journal:  J Oral Microbiol       Date:  2021-11-25       Impact factor: 5.474

4.  Candida albicans Infections: a novel porcine wound model to evaluate treatment efficacy.

Authors:  Joel Gil; Michael Solis; Alexander Higa; Stephen C Davis
Journal:  BMC Microbiol       Date:  2022-02-04       Impact factor: 3.605

5.  Antifungal Activity of Beluntas "Indian Camphorweed" (Pluchea indica) Ethanol Extract on Candida albicans In Vitro Using Different Solvent Concentrations.

Authors:  Wayan Larissa Demolsky; Vinna Kurniawati Sugiaman; Natallia Pranata
Journal:  Eur J Dent       Date:  2021-12-22

6.  Terpinen-4-ol and nystatin co-loaded precursor of liquid crystalline system for topical treatment of oral candidiasis.

Authors:  Renata Serignoli Francisconi; Patricia Milagros Maquera-Huacho; Caroline Coradi Tonon; Giovana Maria Fioramonti Calixto; Janaína de Cássia Orlandi Sardi; Marlus Chorilli; Denise Madalena Palomari Spolidorio
Journal:  Sci Rep       Date:  2020-07-31       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.